Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health


Personal tools

You are here: Home / Biomarkers / CCL28



This biomarker is also known as:
  • CCK1,
  • SCYA28,
  • chemokine (C-C motif) ligand 28 splice variant chi,
  • Mucosae-associated epithelial chemokine,
  • CC chemokine CCL28,
  • MEC,
  • Small-inducible cytokine A28,
  • C-C motif chemokine 28,
  • small-inducible cytokine A28,
  • chemokine (C-C motif) ligand 28,
  • Protein CCK1,
  • small inducible cytokine subfamily A (Cys-Cys), member 28,
  • mucosae-associated epithelial chemokine,
  • small inducible cytokine A28,

View in BioMuta


CCL28 is a member of the small cytokine CC subfamily, and is involved in immunoregulatory and inflammatory processes. CC cytokines are characterized by two adjacent cysteines. CCL28 functions as a chemotactic factor for resting CD4 or CD8 T cells and eosinophils. CCL28 binds to CCR3 and CCR10 and induces calcium mobilization in a dose-dependent manner.


QA State: Curated
Type: Protein
Short Name:


There are no datasets associated with this biomarker.


The following organs have data associated with this biomarker…



Phase: Two
QA State: Under Review


CCL28 was present at higher levels among cases compared to controls with reasonable AUC values.

Performance Comment

CCL28 was one of numerous potential early detection biomarkers specific to triple-negative breast cancer in multiple pathways identified.


This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at if you should have access to this biomarker.


The final report of the 2013 Cancer Biomarkers Bioinformatics Workshop is now available.

Announcement 03/06/2014

Thank you to everyone who helped make the 27th EDRN Steering Committee Meeting a success. We look forward to seeing everyone at the 9th EDRN Scientific Workshop from September 8-11, 2014 in Washington D.C.